用aHSCT治疗的侵袭性MOGAD形式:一个病例报告
Elvira Sbragia1,2, Giacomo Boffa1, Riccardo Varaldo3
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
Multiple sclerosis (Houndmills, Basingstoke, England)
|December 20, 2023
概括
自主造血干细胞移植 (aHSCT) 提供了一种安全有效的治疗方法,用于侵袭性髓-基细胞-糖蛋白抗体相关疾病 (MOGAD),在耐火病例中抑制疾病活动超过两年.
科学领域:
- 神经免疫学 神经免疫学
- 中枢神经系统的脱叶林性疾病.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 髓-寡 dendrocyte-glycoprotein抗体相关疾病 (MOGAD) 可能出现严重的复发和残疾,具有挑战性的治疗方法.
- 目前对MOGAD的治疗方法通常是根据神经髓炎光学谱系障碍 (NMOSD) 进行的,并依赖于临床经验.
- 激进的MOGAD形式需要探索新的和有效的治疗策略.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.4K
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.4K
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...